Ziming Du
Ziming Du
Brigham and Women's Hospital, Harvard Medical School
在 BICS.BWH.HARVARD.EDU 的電子郵件地址已通過驗證
標題引用次數年份
miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer
Y Zhang, LX Yan, QN Wu, ZM Du, J Chen, DZ Liao, MY Huang, JH Hou, ...
Cancer research 71 (10), 3552-3562, 2011
2642011
Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A
ZM Du, LF Hu, HY Wang, LX Yan, YX Zeng, JY Shao, I Ernberg
PloS one 6 (4), 2011
1032011
Eight-signature classifier for prediction of nasopharyngeal carcinoma survival
HY Wang, BY Sun, ZH Zhu, ET Chang, KF To, JSG Hwang, H Jiang, ...
Journal of clinical oncology 29 (34), 4516-4525, 2011
1002011
Upregulation of caveolin‐1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients
ZM Du, CF Hu, Q Shao, MY Huang, CW Kou, XF Zhu, YX Zeng, JY Shao
International journal of cancer 125 (8), 1832-1841, 2009
852009
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
Z Du, M Abedalthagafi, AA Aizer, AR McHenry, HH Sun, MA Bray, ...
Oncotarget 6 (7), 4704, 2015
722015
Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in …
J Li, HY Mo, G Xiong, L Zhang, J He, ZF Huang, ZW Liu, QY Chen, ZM Du, ...
Journal of Biological Chemistry 287 (42), 35484-35495, 2012
552012
ARID1A and TERT promoter mutations in dedifferentiated meningioma
MS Abedalthagafi, WL Bi, PH Merrill, WJ Gibson, MF Rose, Z Du, ...
Cancer genetics 208 (6), 345-350, 2015
452015
Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
J Tang, R Deng, RZ Luo, GP Shen, MY Cai, ZM Du, S Jiang, MT Yang, ...
Breast cancer research and treatment 134 (2), 549-560, 2012
402012
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
Y Mei, WL Bi, NF Greenwald, Z Du, NYR Agar, UB Kaiser, ...
Oncotarget 7 (47), 76565, 2016
312016
Reduced expression of ZDHHC2 is associated with lymph node metastasis and poor prognosis in gastric adenocarcinoma
SM Yan, JJ Tang, CY Huang, SY Xi, MY Huang, JZ Liang, YX Jiang, YH Li, ...
PloS one 8 (2), 2013
312013
Decreased FOXJ1 expression and its ciliogenesis programme in aggressive ependymoma and choroid plexus tumours
MS Abedalthagafi, MP Wu, PH Merrill, Z Du, T Woo, SH Sheu, S Hurwitz, ...
The Journal of pathology 238 (4), 584-597, 2016
162016
Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma
I Nawaz, LF Hu, ZM Du, K Moumad, I Ignatyev, TV Pavlova, V Kashuba, ...
Oncotarget 6 (31), 31493, 2015
132015
Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2
YX Jiang, ZM Du, L Jiao, Q Shao, S Fu, JY Shao, XF Zhu, I Ernberg, YH Li
International journal of clinical and experimental medicine 8 (6), 8472, 2015
122015
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma
S Coy, R Rashid, JR Lin, Z Du, AM Donson, TC Hankinson, NK Foreman, ...
Neuro-oncology 20 (8), 1101-1112, 2018
112018
Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of …
Q Li, L Rane, T Poiret, J Zou, I Magalhaes, R Ahmed, Z Du, N Vudattu, ...
Oncotarget 7 (21), 30230, 2016
92016
Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma
ZM Du, CW Kou, HY Wang, MY Huang, DZ Liao, CF Hu, J Chen, LX Yan, ...
Head & neck 34 (10), 1456-1464, 2012
92012
Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade
IF Dunn, Z Du, M Touat, MB Sisti, PY Wen, R Umeton, AM Dubuc, ...
JCO precision oncology 2018, 2018
82018
Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
Y Mei, Z Du, C Hu, NF Greenwald, M Abedalthagafi, NYR Agar, GP Dunn, ...
Cell communication and signaling 15 (1), 34, 2017
82017
Distinct patterns of primary and motile cilia in Rathke’s cleft cysts and craniopharyngioma subtypes
S Coy, Z Du, SH Sheu, T Woo, FJ Rodriguez, MW Kieran, S Santagata
Modern Pathology 29 (12), 1446-1459, 2016
82016
Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging
Z Du, JR Lin, R Rashid, Z Maliga, S Wang, JC Aster, B Izar, PK Sorger, ...
Nature protocols 14 (10), 2900-2930, 2019
32019
系統目前無法執行作業,請稍後再試。
文章 1–20